103 related articles for article (PubMed ID: 9764832)
1. Anchorage-dependent expression of the vitamin D receptor in normal human keratinocytes.
Segaert S; Garmyn M; Degreef H; Bouillon R
J Invest Dermatol; 1998 Oct; 111(4):551-8. PubMed ID: 9764832
[TBL] [Abstract][Full Text] [Related]
2. Suppression of vitamin D receptor and induction of retinoid X receptor alpha expression during squamous differentiation of cultured keratinocytes.
Segaert S; Garmyn M; Degreef H; Bouillon R
J Invest Dermatol; 2000 Mar; 114(3):494-501. PubMed ID: 10692108
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes.
Sølvsten H; Svendsen ML; Fogh K; Kragballe K
Arch Dermatol Res; 1997 May; 289(6):367-72. PubMed ID: 9209684
[TBL] [Abstract][Full Text] [Related]
4. The antiproliferative and differentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes.
Chen TC; Persons K; Liu WW; Chen ML; Holick MF
J Invest Dermatol; 1995 Jan; 104(1):113-7. PubMed ID: 7798628
[TBL] [Abstract][Full Text] [Related]
5. Hairless suppresses vitamin D receptor transactivation in human keratinocytes.
Xie Z; Chang S; Oda Y; Bikle DD
Endocrinology; 2006 Jan; 147(1):314-23. PubMed ID: 16269453
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal role of vitamin D receptor on β-catenin regulated keratinocyte proliferation and differentiation.
Hu L; Bikle DD; Oda Y
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():237-41. PubMed ID: 24239508
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice.
Sakai Y; Demay MB
Endocrinology; 2000 Jun; 141(6):2043-9. PubMed ID: 10830288
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
10. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
11. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of and response to 1,25 dihydroxycholecalciferol by subpopulations of murine epidermal keratinocytes: existence of a paracrine system for 1,25 dihydroxycholecalciferol.
Rizk-Rabin M; Zineb R; Zhor B; Michèle G; Jana P
J Cell Physiol; 1994 Apr; 159(1):131-41. PubMed ID: 8138581
[TBL] [Abstract][Full Text] [Related]
14. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes.
Xie Z; Bikle DD
J Invest Dermatol; 1998 May; 110(5):730-3. PubMed ID: 9579536
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
Gniadecki R
Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
[TBL] [Abstract][Full Text] [Related]
18. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor expression is linked to cell cycle control in normal human keratinocytes.
Segaert S; Degreef H; Bouillon R
Biochem Biophys Res Commun; 2000 Dec; 279(1):89-94. PubMed ID: 11112422
[TBL] [Abstract][Full Text] [Related]
20. The flavonoid apigenin suppresses vitamin D receptor expression and vitamin D responsiveness in normal human keratinocytes.
Segaert S; Courtois S; Garmyn M; Degreef H; Bouillon R
Biochem Biophys Res Commun; 2000 Feb; 268(1):237-41. PubMed ID: 10652242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
